These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1339115)
1. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial. Díaz-Llopis M; Martos MJ; España E; Cervera M; Vila AO; Navea A; Molina FJ; Romero FJ Doc Ophthalmol; 1992; 82(4):297-305. PubMed ID: 1339115 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal ganciclovir pharmacokinetics in rabbits and man. Ashton P; Brown JD; Pearson PA; Blandford DL; Smith TJ; Anand R; Nightingale SD; Sanborn GE J Ocul Pharmacol; 1992; 8(4):343-7. PubMed ID: 1336537 [TBL] [Abstract][Full Text] [Related]
5. Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir. Anand R; Font RL; Fish RH; Nightingale SD Ophthalmology; 1993 Jul; 100(7):1032-9. PubMed ID: 8391675 [TBL] [Abstract][Full Text] [Related]
6. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits. Le Bourlais C; Chevanne F; Ropert P; Bretagne G; Acar L; Zia H; Sado PA; Needham T; Leverge R J Microencapsul; 1996; 13(4):473-80. PubMed ID: 8808783 [TBL] [Abstract][Full Text] [Related]
7. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device. Sanborn GE; Anand R; Torti RE; Nightingale SD; Cal SX; Yates B; Ashton P; Smith T Arch Ophthalmol; 1992 Feb; 110(2):188-95. PubMed ID: 1310587 [TBL] [Abstract][Full Text] [Related]
8. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS. Akula SK; Ma PE; Peyman GA; Rahimy MH; Hyslop NE; Janney A; Ashton P Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546 [TBL] [Abstract][Full Text] [Related]
9. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir. Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with intravitreous ganciclovir in cytomegalovirus retinitis associated with AIDS]. Gutiérrez A; Martín I; Ferrer E; Torrón C; Aguirre JM Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):629-30. PubMed ID: 1337981 [No Abstract] [Full Text] [Related]
11. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Arevalo JF; Garcia RA; Mendoza AJ Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674 [TBL] [Abstract][Full Text] [Related]
13. A modified procedure for intravitreal injections of ganciclovir in the treatment of cytomegalovirus retinitis. Baudouin C; Gastaud P Ophthalmology; 1992 Aug; 99(8):1183. PubMed ID: 1325043 [No Abstract] [Full Text] [Related]
14. High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis. Young SH; Morlet N; Heery S; Hollows FC; Coroneo MT Med J Aust; 1992 Sep; 157(6):370-3. PubMed ID: 1333036 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Cochereau-Massin I; Lehoang P; Lautier-Frau M; Zazoun L; Marcel P; Robinet M; Matheron S; Katlama C; Gharakhanian S; Rozenbaum W Ophthalmology; 1991 Sep; 98(9):1348-53; discussion 1353-5. PubMed ID: 1658703 [TBL] [Abstract][Full Text] [Related]
16. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis]. Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241 [TBL] [Abstract][Full Text] [Related]
17. Technique of intravitreal injection. Morlet N; Young S; Strachan D; Coroneo MT Aust N Z J Ophthalmol; 1993 May; 21(2):130-1. PubMed ID: 8392851 [No Abstract] [Full Text] [Related]
18. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
19. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir. Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. Kuppermann BD; Quiceno JI; Flores-Aguilar M; Connor JD; Capparelli EV; Sherwood CH; Freeman WR J Infect Dis; 1993 Dec; 168(6):1506-9. PubMed ID: 8245536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]